<DOC>
	<DOCNO>NCT00126373</DOCNO>
	<brief_summary>The investigator test hypothesis Wellbutrin ( bupropion ) give clinical remission Crohn 's disease .</brief_summary>
	<brief_title>A Trial Wellbutrin Crohn 's Disease</brief_title>
	<detailed_description>Wellbutrin ( bupropion ) approve use antidepressant . There case people Wellbutrin significant improvement clinically Crohn 's disease . In trial , hypothesis Wellbutrin induce clinical remission Crohn 's disease test . The investigator also look see Wellbutrin low level inflammatory cytokine tumor necrosis factor-alpha ( TNF ) .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Moderate severe Crohn 's disease 220 &lt; CDAI &lt; 400 . All patient study must antiTNF antibody least eight week . Patients exclude study fulminant Crohn 's disease require parenteral steroid treatment , hospitalization , need surgery imminently . Patients serious infection precede three month , opportunistic infection within one month , current sign symptom severe , progressive uncontrolled renal , hepatic , hematologic , endocrine , pulmonary , cardiac , neurological , cerebral disease exclude . Patients also exclude study history seizure , epilepsy , presume current central nervous system tumor , anorexia nervosa bulimia , currently take take last four week drug monoamine oxidase inhibitor class , allergic Wellbutrin . Patients active major depression suicidal ideation exclude , patient score 19 high Beck depression inventory . Patients exclude currently take medicine selective serotonin reuptake class , mirtazapine , venlafaxine , tricyclic antidepressant , mood stabilizing , antipsychotic medication previous two week . Patients exclude currently abuse alcohol alcohol dependence . Patients exclude study baseline liver function test great twice upper limit normal , clinical investigator believe baseline chemistry , liver function test complete blood count contraindicates entry study . Pregnant lactate female exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Crohn disease</keyword>
	<keyword>TNF-alpha</keyword>
</DOC>